Anti-Human CD68 In Vivo Antibody - Low Endotoxin
- SKU:
- IVMB0252
- Product Type:
- In Vivo Monoclonal Antibody
- Clone:
- KP1
- Protein:
- CD68
- Isotype:
- IgG1 k
- Reactivity:
- Human
- Research Area:
- Immunology
- Endotoxin Level:
- Low Endotoxin
- Host Species:
- Mouse
- Applications:
- Blocking
- Applications:
- Dot
- Applications:
- EM
- Applications:
- FC
- Applications:
- ICC
- Applications:
- ICFC
- Applications:
- IHC
- Applications:
- IHC FFPE
- Applications:
- In Vivo
- Applications:
- IP
- Applications:
- WB
Description
Product Name: | Anti-Human CD68 In Vivo Antibody - Low Endotoxin |
Product Code: | IVMB0252 |
Size: | 1 mg, 5 mg, 25 mg, 50 mg, 100 mg |
Clone: | KP1 |
Product Type: | Monoclonal Antibody |
Isotype: | IgG1 k |
Reactivity: | Human |
Applications: | B, Dot, EM, FC, ICC, ICFC, IHC, IHC FFPE, In Vivo, IP, WB |
Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Purity: | ≥95% monomer by analytical SEC ⋅ >95% by SDS Page |
Product Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
Applications: | B, Dot, EM, FC, ICC, ICFC, IHC, IHC FFPE, In Vivo, IP, WB |
Reactivity: | Human |
Host Species: | Mouse |
Specificity: | Anti-CD68 antibody (clone KP1) activity is directed against human CD68. |
Antigen Distribution: | CD68 is found in the cytoplasm of monocytes/macrophages, fibroblasts, human peripheral blood lymphocytes, neutrophil primary and mast cell granules, large granular lymphocytes, basophils, basal epithelial cell layers, renal glomeruli, myeloid cells, endothelial cells, retinal epithelial cells, osteoblasts, fibroblast-like cells from bone marrow, and a wide-range of lymphoid neoplasms. CD68 is predominantly located in lysosomal membranes, with a small amount on the cell surface. Additionally, CD68 can be expressed in most hematopoietic cell lines by phorbol-induced differentiation; soluble CD68 can also be found in serum and urine. |
Concentration: | ≥ 5.0 mg/ml |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Purity: | ≥95% monomer by analytical SEC ⋅ >95% by SDS Page |
Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
Storage and Handling: | Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -70°C. Avoid Repeated Freeze Thaw Cycles. |
Research Area: | Immunology |
NCBI Gene Bank ID: | 968 |